日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
2011/01/14 | 02 : 00 | PR Newswire (US) | ANGIOTECH PHARMACEUTICALS ANNOUNCES DELISTING FROM THE NASDAQ STOCK MARKET AND TRANSFER TO OTCQB™ MARKETPLACE | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
2011/01/13 | 05 : 00 | PR Newswire (US) | Angiotech Pharmaceuticals, Inc. Announces Agreement with Consenting Noteholders to Extend Certain Deadlines under Support Agreem | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
2011/01/07 | 07 : 26 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
2011/01/07 | 06 : 48 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
2011/01/06 | 10 : 00 | PR Newswire (US) | ANGIOTECH PHARMACEUTICALS ANNOUNCES NOTICE OF DELISTING FROM THE NASDAQ STOCK MARKET | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
2010/12/24 | 01 : 49 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
2010/12/23 | 04 : 30 | PR Newswire (US) | Angiotech Pharmaceuticals, Inc. Announces Agreement to Extend Cure Period Under Subordinated Note Indenture | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
2010/12/18 | 06 : 48 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
2010/12/18 | 02 : 00 | PR Newswire (US) | Angiotech Pharmaceuticals, Inc. Announces Agreement with Consenting Noteholders to Extend Certain Deadlines under Support Agreem | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
2010/12/03 | 07 : 20 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
2010/12/03 | 02 : 18 | PR Newswire (US) | Angiotech Pharmaceuticals, Inc. Announces Preliminary Injunction Ruling In Connection With Rex Medical L.P. Litigation | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
2010/12/03 | 02 : 00 | PR Newswire (US) | Angiotech Pharmaceuticals, Inc. Announces Agreement with Consenting Noteholders to Extend Certain Deadlines under Support Agreem | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
2010/11/30 | 02 : 30 | PR Newswire (US) | ANGIOTECH PHARMACEUTICALS ANNOUNCES PRIVATE LABEL PRODUCT SUPPLY AGREEMENT WITH HOLOGIC | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
2010/11/25 | 04 : 15 | PR Newswire (US) | Angiotech Pharmaceuticals, Inc. Announces Commencement of Proceedings by Rex Medical LP | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
2010/11/17 | 07 : 08 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
2010/11/10 | 06 : 35 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
2010/11/10 | 04 : 42 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
2010/11/09 | 19 : 00 | PR Newswire (US) | ANGIOTECH PHARMACEUTICALS, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2010 | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
2010/11/02 | 19 : 04 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
2010/10/30 | 09 : 00 | PR Newswire (US) | Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
2010/10/30 | 09 : 00 | PR Newswire (US) | Angiotech Pharmaceuticals, Inc. Announces a Strongly Supported Transaction Agreement with Majority of Senior Subordinated Noteho | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
2010/10/14 | 08 : 00 | PR Newswire (US) | ANGIOTECH PHARMACEUTICALS ANNOUNCES CONFERENCE CALL AND WEBCAST | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
2010/10/07 | 03 : 57 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
2010/10/06 | 21 : 00 | PR Newswire (US) | Angiotech Pharmaceuticals, Inc. Announces Commencement of Arbitration and Litigation Proceedings by QSR Holdings, Inc. Against t | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
2010/10/01 | 21 : 00 | PR Newswire (US) | Angiotech Pharmaceuticals, Inc. Defers Interest Payments Under Senior Subordinated Notes. Angiotech Conducting Discussions With | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
2010/09/25 | 00 : 30 | PR Newswire (US) | ANGIOTECH ANNOUNCES THAT COOK MEDICAL'S ZILVER(R) PTX(R) DRUG-ELUTING STENT MEETS ITS PRIMARY ENDPOINT IN A 479-PATIENT, MULTI-C | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
2010/09/24 | 03 : 30 | PR Newswire (US) | ANGIOTECH PHARMACEUTICALS AND PARTNER ATHERSYS ANNOUNCE UPDATED RESULTS FROM PHASE I STUDY OF MULTISTEM(R) IN HEART ATTACK PATIE | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
2010/09/23 | 03 : 45 | PR Newswire (US) | ANGIOTECH ANNOUNCES STRONG OUTCOMES IN DIABETIC PATIENTS TREATED WITH BOSTON SCIENTIFIC CORPORATION'S PLATINUM CHROMIUM TAXUS(R) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
2010/09/23 | 03 : 45 | PR Newswire (US) | ANGIOTECH ANNOUNCES LONG-TERM DATA SHOW ADVANTAGES FOR TAXUS(R) LIBERTÉ(R) STENT IN SMALL VESSELS AND LONG LESIONS | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
2010/08/10 | 05 : 40 | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |